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ABSTRACT
In total, 100 Staphylococcus aureus isolates from diverse cases of skin and soft-tissue infection at a
university hospital in Saxony, Germany, were characterised using diagnostic microarrays. Virulence
factors, including Panton–Valentine leukocidin (PVL), were detected and the isolates were assigned to
clonal groups. Thirty isolates were positive for the genes encoding PVL. Only three PVL-positive
methicillin-resistant S. aureus (MRSA) isolates were found, two of which belonged to European clone
ST80-MRSA IV and one to USA300 strain ST8-MRSA IV. The remaining methicillin-susceptible PVL-
positive isolates belonged to a variety of different multilocus sequence types. The predominant strains
were agrI ⁄ ST22, agrII ⁄CC5, agrIII ⁄CC30 and agrIV ⁄ ST121. In order to check for possible bias caused by
regional or local outbreak strains, an additional 18 methicillin-susceptible, PVL-positive isolates from the
UK were tested. Approximately two-thirds of the UK isolates belonged to types that also comprised
approximately two-thirds of the isolates from Saxony. Some methicillin-susceptible PVL-positive
isolates (agrI ⁄ ST152, agrIII ⁄ ST80 and agrIII ⁄ ST96) closely resembled known epidemic community-
acquired MRSA (CaMRSA) strains. These ﬁndings indicate that the current rise in PVL-positive
CaMRSA could be caused by the dissemination of novel SCCmec elements among pre-existing PVL-
positive strains, rather than by the spread of PVL phages among MRSA strains.
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INTRODUCTION
Staphylococcus aureus is a common pathogen
capable of causing a variety of infections in
humans. These range from minor soft-tissue
infections to life-threatening conditions, e.g.,
septicaemia, toxin-mediated toxic shock or
scalded skin syndromes. One virulence factor
of particular importance is Panton–Valentine
leukocidin (PVL), which is composed of two
separate proteins encoded by two adjacent genes
[1]. Molecules of both proteins together form
heptameric pores that selectively disrupt leuko-
cyte membranes, leading to increased virulence.
Thus, PVL-carrying strains are able to cause
recurrent, chronic or particularly severe skin and
soft-tissue infections [2–7], as well as rapidly fatal
pneumonia [8–11], which occur notably among
previously healthy, immunocompetent individu-
als. In the late 1990s, the ﬁrst PVL-positive
methicillin-resistant S. aureus (MRSA) isolates
were observed [12], and such strains have spread
globally in recent years [10,13]. Currently, there
is a pandemic of PVL-positive MRSA that is
associated with the spread of several distin-
guishable strains [3,7,13–19]. These MRSA strains
are commonly called community-acquired or
community-associated MRSA (CaMRSA), as
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they are not restricted to the healthcare envi-
ronment. While PVL production is a common
trait among CaMRSA, it is important to recog-
nise that PVL-negative strains can also occur
[20].
This is not the ﬁrst occasion on which PVL-
positive S. aureus strains have caused a pan-
demic. The PVL toxin was discovered in 1932
[21], although evidence of its existence was
documented in the late 19th century [22]. The
laboratory strains ATCC 25923 [13,23] and the
‘Oxford Staphylococcus’ strain [24], which are
both used by many microbiology laboratories as
drug-susceptible quality control strains, are
PVL-positive isolates from the 1940s. The closely
related phage type 80 ⁄ 81 strain acquired peni-
cillinase and spread worldwide during the
1950s and 1960s. Later, this strain virtually
disappeared, perhaps following widespread
use of penicillinase-resistant penicillins and
cephalosporins. One of the currently spreading
PVL-positive CaMRSA clones (ST30, West
Samoan phage pattern strain) is related to,
and is thought to have evolved from, these
pandemic clones [13,25]. However, a notable
feature of the current epidemic of CaMRSA is
the genetic diversity of PVL-positive MRSA
strains [13,16], which derive from several dif-
ferent clonal complexes (CCs), as deﬁned by
multilocus sequence typing (MLST) [26]. There-
fore, it can be assumed either that PVL-encod-
ing genes have spread among diverse MRSA
strains (which is compatible with their phage-
borne nature [27,28]), or that SCCmec elements
encoding methicillin resistance [29–31] have
spread among pre-existing PVL-positive methi-
cillin-susceptible S. aureus (MSSA).
In order to investigate the origin of the diver-
sity of PVL-positive MRSA, the present study
screened S. aureus isolates from skin and soft-
tissue infections for PVL-encoding genes, and
assigned them to speciﬁc CCs using a previously
developed diagnostic DNA microarray [7,13,32].
It was hypothesised that this approach might help
to identify ancestors of pandemic PVL-positive
CaMRSA strains and allow a greater understand-
ing of their success and worldwide emergence.
Moreover, this study aimed to provide insights
into the prevalence and epidemiology of PVL-
positive strains in a setting in which CaMRSA
strains are still thought to be rare (Saxony,
Germany).
MATERIALS AND METHODS
Isolates
Isolates were obtained from routine diagnostic specimens
submitted to the Institute for Hygiene and Medical Microbi-
ology at the Technical University of Dresden, Germany. In
total, 100 consecutive S. aureus isolates were collected, for
which one of the following diagnoses was provided: abscess,
abscessing mastitis, chronic soft-tissue infection, complicated
acne, erysipelas, ﬁstulating soft-tissue infection, furunculosis,
phlegmon or paronychia. Subsequent isolates from the same
patient, or isolates from screening swabs of contacts of MRSA-
positive individuals, were excluded. To address possible
sample bias associated with strains prevalent in Dresden,
and to determine whether PVL-positive strains were locally
restricted or widespread, 18 PVL-positive S. aureus isolates
from England were studied in parallel. These 18 isolates were
selected at random from isolates referred to the UK Staphylo-
coccus Reference Laboratory (Centre for Infections, Health
Protection Agency, London, UK) over a 2-year period (2004–
2006). The isolates were recovered from individuals presenting
with abscesses, and were epidemiologically unrelated. Refer-
ence strains used for array evaluation have been described
previously [7,13].
All isolates were cultured in Columbia blood broth (Oxoid,
Wesel, Germany) and incubated overnight at 37C. Genomic
DNA was prepared by resuspending a loopful of culture
material in 100 lL of lysis solution containing 0.05 mg of
lysostaphin (AMBI Products, Lawrence, NY, USA), 2 mg of
lysozyme (Sigma, Steinheim, Germany), 2 mg of ribonucle-
ase A (Sigma), 2 lL of 20 mM Tris-HCl, pH 8.0, 2 lL of 2 mM
EDTA and 1 lL of Triton X-100. After incubation for 45 min at
37C on a shaker (300 rpm), 10 lL of proteinase K and 100 lL
of buffer AL (DNeasy kit; Qiagen, Hilden, Germany) were
added. After a second incubation period (45 min at 56C), the
samples were processed using the Qiagen EZ1 device accord-
ing to the tissue lysis protocol supplied by the manufacturer.
Array procedures
DNA microarrays were manufactured and processed as
described previously [7,13,32], using the ArrayTube system
(AT) (CLONDIAG chip technologies, Jena, Germany). The
hybridisation probes and ampliﬁcation primers were directed
towards species-speciﬁc markers of S. aureus, antibiotic resis-
tance determinants and exotoxins. For typing purposes, allelic
variants of the accessory gene regulator (agr) gene cluster and
set ⁄ ssl genes were included. Targets and sequence data for
probes and primers are listed in Table S1 (see Supplementary
material). Probes were spotted in two-fold redundancy. Eval-
uation and trials of the assay have been described previously
[7,13,32]. MRSA and MSSA isolates related to known epidemic
MRSA strains (see below) were additionally tested using an
expanded set of probes that encompassed markers carried by
SCCmec cassettes (i.e., ccrA, ccrB, dcs region, DmecR, mecR, mecI
and ugpQ).
Genomic target DNA was ampliﬁed in a thermally syn-
chronised linear multiplex reaction, using one primer for each
target sequence. This ampliﬁcation was also used to incorpo-
rate biotin-16-dUTP (Roche, Penzberg, Germany) for internal
labelling. Reaction conditions have been described in detail
previously [13,32]. Some isolates were also examined using an
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alternative protocol, based on a whole genome ampliﬁcation
with partially randomised primers [7], in order to detect allelic
variants not covered by published sequence data.
Biotinylated single-stranded amplicons were then hybri-
dised to the array. The hybridisation was visualised using
streptavidin–horseradish peroxidase-mediated precipitation of
the chromogenic substrate Seramun green (Seramun, Woizig,
Germany). Data analysis was performed using the ATR01
reading device and the Iconoclust software package (CLON-
DIAG chip technologies). Data interpretation and threshold
deﬁnition was performed as described previously [13].
Strain identiﬁcation
spa typing was performed as described previously [33], and
representative isolates of all strains (42 of 118 isolates) were
typed using this method. Types were assigned using the
nomenclature described on the Ridom SpaServer website
(http:// www.spa.ridom.de) and SPATYPEMAPPER
software (CLONDIAG chip technologies; freely downloadable
at http://www.clondiag.com/technologies/download.php?
ﬁle=spa).
Assignment of isolates to MLST groups was inferred on the
basis of spa types and comparison of hybridisation patterns
with strains of known MLST type. Some isolates that could not
be assigned in this way were subjected to MLST typing as
described previously [26].
RESULTS
Prevalence of PVL and methicillin resistance
among the Saxony isolates
Afﬁliations and prevalence of the isolates are
shown in Fig. 1 (PVL-positive isolates) and
Fig. 2 (PVL-negative isolates). Thirty of the 100
isolates were positive for the genes encoding
PVL. Of these, three were MRSA; two of these
belonged to European clone ST80-MRSA IV
[7,19,34] and one to the USA300 strain ST8-
MRSA IV [35,36]. The remaining methicillin-
susceptible, PVL-positive isolates belonged to a
variety of different MLST types. The predomi-
nant strains were agrI ⁄ ST22, agrII ⁄CC5,
agrIII ⁄CC30 and agrIV ⁄ ST121.
Two methicillin-susceptible isolates resembled
a ST152 CaMRSA strain from the Balkans [13] in
terms of their hybridisation proﬁles and spa type
(t355). Another isolate appeared to be a methicil-
lin-susceptible variant or precursor of European
clone ST80-MRSA IV that carried the same viru-
lence factors [7], but no resistance genes except for
tetK. This isolate belonged to spa type t044.
Among the 70 PVL-negative isolates, agrI ⁄CC8
and agrIII ⁄CC30 were the most common strains.
Four of these were MRSA; one belonged to
agrI ⁄ ST8 and carried an atypical SCCmecIV ele-
ment, two belonged to the Berlin epidemic MRSA
(agrI ⁄ ST45) [37,38], and one belonged to the South
German epidemic MRSA (agrII ⁄CC5, ST228)
[37,38].
Comparison of PVL-positive MSSA from
Saxony and UK
To address a possible regional bias, 18 PVL-
positive MSSA strains from the UK were analysed
in parallel with the 27 PVL-positive MSSA strains
from Saxony. Approximately two-thirds of the
UK isolates belonged to strains that also com-
prised approximately two-thirds of the isolates
from Saxony (i.e., agrI ⁄ ST22, agrIII ⁄CC30 and
agrIV ⁄ ST121) (Fig. 3). The remainder comprised
a range of different strains.
Fig. 1. Afﬁliations and prevalence
of Panton–Valentine leukocidin-
positive strains of Staphylococcus aur-
eus from Saxony. Numbers of isolates
are given in brackets. MSSA, methi-
cillin-susceptible S. aureus; MRSA,
methicillin-resistant S. aureus.
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Distribution of other virulence factors among
the isolates from Saxony
Other important virulence factors detected in-
cluded tst-1 (n = 15), sea (n = 25), seb (n = 7), sec+l
(n = 10), sed+j+r (n = 16), the egc locus (n = 53)
and sek+q (n = 4). The haemolysin-a gene hla was
found in 96 isolates, the untruncated haemolysin-
b gene (hlb) was detected in seven isolates, and all
isolates were haemolysin-d (hld)-positive. Haem-
olysin-c genes (lukF ⁄S, hlgA) were detected in 92
isolates, although the existence of a deviant allelic
variant can also be assumed for the remaining
eight isolates (ST22 and ST152), based on positive
results obtained using an alternative ampliﬁcation
and labelling technique [7]. Leukocidin genes
(lukD ⁄E) were found in 40% of isolates. Interest-
ingly, deviant alleles of this locus might exist, as
only one of two components was detectable in a
number of study isolates (e.g., lukE in ST121
isolates). Exfoliative toxin A (etA) was found
twice, and etD was found in ﬁve isolates. The
latter occurred together with edinB, which was
found in seven isolates.
Strain characteristics
While particular virulence- or resistance-associ-
ated genes or gene complexes (e.g., complete
pathogenicity islands or the egc enterotoxin clus-
Fig. 2. Afﬁliations and prevalence of
Panton–Valentive leukocidin-nega-
tive strains of Staphylococcus aureus
from Saxony.Numbers of isolates are
given in brackets. MSSA, methicillin-
susceptible S. aureus; MRSA, methi-
cillin-resistant S. aureus.
Fig. 3. Comparison of afﬁliations
and prevalence of Panton–Valentine
leukocidin-positive, methicillin-sus-
ceptible isolates of Staphylococcus
aureus from Saxony and England.
Numbers of isolates are given in
brackets. MSSA, methicillin-suscep-
tible S. aureus; MRSA, methicillin-
resistant S. aureus.
1160 Clinical Microbiology and Infection, Volume 13 Number 12, December 2007
 2007 The Authors
Journal Compilation  2007 European Society of Clinical Microbiology and Infectious Diseases, CMI, 13, 1157–1164
ter) were not characteristic of particular strains or
CCs, the complete hybridisation proﬁle of a given
isolate facilitated assessment of its relatedness to
known strains or previously characterised CCs
(Fig. S1, see Supplementary material). These
assessments were in good agreement with the
spa-typing data. The most important strains and
isolates are described brieﬂy below; complete
proﬁles are shown in Fig. S1.
agr group I ⁄CC8 strains formed a group with
variable leukocidin and enterotoxin content,
which otherwise resembled sequenced strains
NCTC 8325 and COL. All 25 MSSA strains were
PVL-negative. One isolate from this clonal group
that carried a SCCmecIV element was found in a
swab from an Ethiopian immigrant child with
recurrent furunculosis. Another MRSA isolate
belonged to the USA300 CaMRSA strain and
carried a SCCmecIV element, as well as msrA
(macrolide resistance), aphA3 (neomycin ⁄ kana-
mycin resistance) and sat (streptothricin resis-
tance) genes. This isolate was among the ﬁrst
isolates of that strain in the Dresden region of
Saxony (isolated in May 2005).
agr group I ⁄CC25 isolates had similar hybridi-
sation proﬁles to CC8, but differed in spa type and
by the presence of a pathogenicity island com-
prising edinB and etD. No PVL-positive clinical
isolates belonging to this group were found in
the present study, but one reference strain
(NARSA 158) harboured PVL-encoding genes
and belonged to this group.
agr group I ⁄CC59 was represented by a single
PVL-negative, methicillin-susceptible isolate
belonging to spa type t1151.
CC22, CC45 and CC152 also belonged to agr
group I, but produced deviant hybridisation
patterns, especially with regard to the set ⁄ ssl
genes.
agr group I ⁄CC22 could be roughly divided into
four strains, based on the presence of mecA and
PVL-encoding genes. Both PVL-negative, mecA-
negative and PVL-positive, mecA-negative isolates
were detected. The latter occurred in the UK as
well as in Saxony. In a previous study [13], mecA-
positive, PVL-negative (Barnim epidemic MRSA,
ST22-MRSA IV) [37,39] and mecA-positive, PVL-
positive isolates have been characterised, but
neither was found in the present study.
agr group I ⁄CC45 comprised both MSSA and
MRSA isolates. The latter belonged to the
Berlin epidemic strain (ST45-MRSA IV) [37,38].
PVL-encoding genes were not detected among
isolates from this group.
agr group I ⁄CC152 (spa t355) comprised two
PVL-positive, mecA-negative isolates that carried
edinB, but not etD, and which had an unusual
set ⁄ ssl pattern. A related PVL-positive MRSA
strain has been characterised previously [13,40];
however, in contrast to that strain, the present
isolate did not contain recombinase genes or
ugpQ, both of which are associated with the
SCCmecV element.
agr group II ⁄CC5 was represented by a cluster
of isolates that closely resembled the sequenced
strains Mu50 and N315. One MRSA isolate
belonged to the South German epidemic strain
[37,38], which is an SCCmecI strain that is very
common in Saxony. However, this isolate was
atypical in having a truncated egc enterotoxin
gene cluster (seo-positive, but negative for seg, sel,
sem, sen and seu). Three MSSA isolates harboured
PVL-encoding genes, and ﬁve were positive for
sed, sej and ser.
Ten isolates belonging to agr group II had t160
(or related) spa sequences. One representative
isolate was further analysed by MLST and was
characterised as ST582 ⁄CC15. All isolates from
this group were methicillin-susceptible, and two
harboured etA. One isolate with similar hybridi-
sation results carried PVL genes and belonged to
spa t903.
Three isolates belonged to agr group III ⁄ ST1.
One UK isolate from this lineage harboured PVL-
encoding genes, but this virulence factor was not
found among the German isolates studied. How-
ever, PVL-positive MSSA strains belonging to this
group exist in this region as they have been found
previously in a family outbreak in eastern Saxony
(T. Juratzek, personal communication).
Three isolates from agr group III ⁄ ST80 were
found. Two belonged to the PVL-positive Euro-
pean CaMRSA clone [7,19,34] and one was a
PVL-positive, mecA-negative isolate that was
related to the European CaMRSA clone on the
basis of hybridisation pattern and spa type.
Other targets from SCCmecIV cassettes (ccrA2,
ccrB2, dcs region, DmecR and ugpQ) were not
detected.
Isolates from agr group III ⁄CC30 showed a
characteristic hybridisation pattern caused by the
presence of Sanger MRSA252-like alleles of set ⁄ ssl
genes. These alleles clearly set these isolates apart
from other clonal groups, although ST22 and ST45
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appear to be related. All except one isolate
contained the egc enterotoxin gene cluster. Car-
riage of other enterotoxins and tst1 was variable.
PVL-encoding genes were detected in seven of 23
isolates, and these resembled the historic phage
type 80 ⁄ 81 and ATCC 25923 strains. MRSA
strains were not found among these isolates,
although healthcare-associated UK EMRSA-16
and CaMRSA of the West Samoan phage pattern
belong to this clonal group.
A PVL-positive isolate from the UK showed a
hybridisation pattern, as well as spa type t202,
which indicated similarity to a PVL-positive
CaMRSA strain from Australia, i.e., Queensland
clone ST93-MRSA IV [13,41]. In common with this
strain, the UK isolate did not harbour any entero-
toxin genes, gave unusually low hybridisation
signals with set ⁄ ssl probes, and gave a signal with
splA, but not with splB. In contrast to a represen-
tative of the Queensland clone, it did not contain
any of the genes associated with a SCCmecIV
element (ccrA2, ccrB2, dcs region, DmecR and
ugpQ).
agr group IV ⁄ ST121 was a rather common and
homogeneous group, occurring in the UK and in
Saxony. This lineage may have a global distribu-
tion, as it also appears to be involved in most
cases of tropical pyomyositis (W. Witte, personal
communication). Most (15 of 16) isolates were
PVL-positive. No MRSA strains belonging to this
lineage were identiﬁed.
DISCUSSION
The most striking ﬁnding of the present study
was that 30% of routine S. aureus isolates in
Saxony from skin and soft-tissue infections har-
bour PVL genes. Previous studies have indicated
a prevalence of PVL among all S. aureus isolates of
only c. 1%, but this prevalence is clearly much
higher in the present collection of isolates from
patients with pre-selected diagnoses known to be
associated with PVL. It can be assumed that PVL-
positive MSSA strains are rather common, but
that they are usually overlooked, as no routine
test for PVL is available. This reinforces the need
to study the prevalence of PVL-encoding genes
among MSSA isolates from other conditions, e.g.,
pneumonia.
Approximately one-third of the isolates from
skin and soft-tissue infections in Saxony har-
boured PVL-encoding genes. This is a similar
frequency to that indicated by recent epidemio-
logical studies of PVL-positive MRSA isolates in
the USA [42,43]. One possibility is that this
proportion may deﬁne some kind of ecological
niche which is occupied by strains carrying this
virulence factor. The introduction of PVL-positive
MRSA into a setting characterised by a high
selective pressure caused by widespread use of
b-lactam antibiotics is likely to lead to the
replacement of highly diverse populations of
methicillin-susceptible PVL-positive strains by a
few different methicillin-resistant PVL-positive
strains. The current epidemic of PVL-positive
USA300 and USA400 strains in the USA could
thus be interpreted as a replacement of MSSA by
MRSA, rather than as spread of PVL-positive
strains into ecological niches occupied previously
by PVL-negative strains.
The present study highlights the genetic diver-
sity of PVL-positive MSSA isolates. PVL-encoding
genes were detected in strains representing all agr
groups and belonging to most CCs (see above and
[13]). The diversity of PVL-positive strains might
be attributed to the fact that PVL genes are
localised on phages [27,28], which facilitate
spread of PVL genes through S. aureus popula-
tions. The current rise in PVL-positive MRSA
could result either from MRSA acquiring a PVL
phage, or from PVL-positive, methicillin-suscep-
tible strains acquiring a SCCmec element. For ST1
and ST22 PVL-positive MRSA, both possibilities
seem to be applicable, with the characterisation of
ST1 and ST22 isolates containing neither mecA nor
PVL, both determinants together, or either one of
them (see above and [13]). ST80, ST93 and ST152
PVL-positive MRSA could have evolved by the
second pathway, as PVL-positive, mecA-negative
isolates have been identiﬁed rather than PVL-
negative, mecA-positive precursors or relatives. A
similar pathway for the evolution of ST30 PVL-
positive MRSA has been described previously
[25]. Since this development occurred simulta-
neously and independently within several un-
related clonal lines, it can be assumed that the
novel SCCmecIV and SCCmecV elements are
highly mobile, being able to spread through
S. aureus populations in a similar way to phages.
These data provide evidence that the dissemi-
nation of novel SCCmec elements among pre-
existing PVL-positive strains is likely to have
played a major role in the current surge of PVL-
positive CaMRSA, which was therefore not caused
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solely by the epidemic spread of PVL phages
withinMRSApopulations. This supports ahypoth-
esis that the rise of PVL-positive CaMRSA is only
the most conspicuous part of a general evolution
towards b-lactam resistance in S. aureus mediated
by the spread of these elements.
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SUPPLEMENTARY MATERIAL
The following Supplementary material for this
article is available online at http://www.black
well-synergy.com:
Table S1. Targets and sequence data for probes
and primers used in this study.
Fig. S1. Strain characterisations obtained using
diagnostic microarray hybridisation. For compar-
ison purposes, some reference strains are included
(hybridisation data taken from [13]), and these
strains are labelled in italics. Black box, positive;
grey box, variable or equivocal data, with numbers
indicating the number of positive isolates.
REFERENCES
1. Kaneko J, Kamio Y. Bacterial two-component and hetero-
heptameric pore-forming cytolytic toxins: structures, pore-
forming mechanism, and organization of the genes. Biosci
Biotechnol Biochem 2004; 68: 981–1003.
2. Baggett HC, Hennessy TW, Rudolph K et al. Community-
onset methicillin-resistant Staphylococcus aureus associated
with antibiotic use and the cytotoxin Panton–Valentine
leukocidin during a furunculosis outbreak in rural Alaska.
J Infect Dis 2004; 189: 1565–1573.
3. Diep BA, Sensabaugh GF, Somboona NS et al. Widespread
skin and soft-tissue infections due to two methicillin-
resistant Staphylococcus aureus strains harboring the genes
for Panton–Valentine leucocidin. J Clin Microbiol 2004; 42:
2080–2084.
4. Kravitz GR, Dries DJ, Peterson ML et al. Purpura fulmin-
ans due to Staphylococcus aureus. Clin Infect Dis 2005; 40:
941–947.
5. Lina G, Piemont Y, Godail-Gamot F et al. Involvement of
Panton–Valentine leukocidin-producing Staphylococcus
aureus in primary skin infections and pneumonia. Clin
Infect Dis 1999; 29: 1128–1132.
6. Miller LG, Perdreau-Remington F, Rieg G et al. Necrotiz-
ing fasciitis caused by community-associated methicillin-
resistant Staphylococcus aureus in Los Angeles.N Engl J Med
2005; 352: 1445–1453.
7. Monecke S, Slickers P, Hotzel H et al. Microarray-based
characterisation of a Panton–Valentine leukocidin-posi-
tive community-acquired strain of methicillin-resistant
Staphylococcus aureus. Clin Microbiol Infect 2006; 12: 718–
728.
8. Francis JS, Doherty MC, Lopatin U et al. Severe commu-
nity-onset pneumonia in healthy adults caused by
methicillin-resistant Staphylococcus aureus carrying the
Panton–Valentine leukocidin genes. Clin Infect Dis 2005;
40: 100–107.
9. Gillet Y, Issartel B, Vanhems P et al. Association between
Staphylococcus aureus strains carrying gene for Panton–
Valentine leukocidin and highly lethal necrotising pneu-
monia in young immunocompetent patients. Lancet 2002;
359: 753–759.
10. Vandenesch F, Naimi T, Enright MC et al. Community-
acquired methicillin-resistant Staphylococcus aureus
carrying Panton–Valentine leukocidin genes: worldwide
emergence. Emerg Infect Dis 2003; 9: 978–984.
11. van der Flier M, van Dijk NB, Fluit AC et al. Fatal pneu-
monia in an adolescent due to community-acquired
methicillin-resistant Staphylococcus aureus positive for
Panton–Valentine-leukocidin. Ned Tijdschr Geneeskd 2003;
147: 1076–1079.
12. Anonymous. Four pediatric deaths from community-
acquired methicillin-resistant Staphylococcus aureus—Min-
nesota and North Dakota, 1997–1999. JAMA 1999; 282:
1123–1125.
13. Monecke S, Berger-Ba¨chi B, Coombs C et al. Compara-
tive genomics and DNA-array-based genotyping of
pandemic Staphylococcus aureus strains carrying Panton–
Valentine leukocidin. Clin Microbiol Infect 2007; 13: 236–
249.
14. Dagnra AY, Tristan A, Gillet Y et al. New emerging
Staphylococcus aureus strains. Rev Prat 2004; 54: 1053–
1058.
15. Dufour P, Gillet Y, Bes M et al. Community-acquired
methicillin-resistant Staphylococcus aureus infections in
France: emergence of a single clone that produces
Panton–Valentine leukocidin. Clin Infect Dis 2002; 35:
819–824.
16. Holmes A, Ganner M, McGuane S et al. Staphylococcus
aureus isolates carrying Panton–Valentine leucocidin genes
in England and Wales: frequency, characterization, and
association with clinical disease. J Clin Microbiol 2005; 43:
2384–2390.
17. Linde H, Wagenlehner F, Strommenger B et al.Healthcare-
associated outbreaks and community-acquired infections
due to MRSA carrying the Panton–Valentine leucocidin
gene in southeastern Germany. Eur J Clin Microbiol Infect
Dis 2005; 24: 419–422.
18. Maier J, Melzl H, Reischl U et al. Panton–Valentine leuk-
ocidin-positive methicillin-resistant Staphylococcus aureus
in Germany associated with travel or foreign family origin.
Eur J Clin Microbiol Infect Dis 2005; 24: 637–639.
Monecke et al. PVL-positive MSSA 1163
 2007 The Authors
Journal Compilation  2007 European Society of Clinical Microbiology and Infectious Diseases, CMI, 13, 1157–1164
19. Witte W, Braulke C, Cuny C et al. Emergence of methi-
cillin-resistant Staphylococcus aureus with Panton–Valen-
tine leukocidin genes in central Europe. Eur J Clin
Microbiol Infect Dis 2005; 24: 1–5.
20. Coombs GW, Nimmo GR, Bell JM et al. Genetic diversity
among community methicillin-resistant Staphylococcus
aureus strains causing outpatient infections in Australia.
J Clin Microbiol 2004; 42: 4735–4743.
21. Panton P, Valentine F. Staphylococcal toxin. Lancet 1932; i:
506–508.
22. Van de Velde H. Etude sur le me´canisme de la virulence
du Staphylocoque pyoge`ne. La Cellule 1894; 10: 401–410.
23. Dunne WM. Panton–Valentine leukocidin genes in a lab-
oratory quality control strain of Staphylococcus aureus.
J Clin Microbiol 2006; 44: 287.
24. Kearns AM, Ganner M, Holmes A. The ‘Oxford Staphy-
lococcus’: a note of caution. J Antimicrob Chemother 2006;
58: 480–481.
25. Robinson DA, Kearns AM, Holmes A et al. Re-emergence
of early pandemic Staphylococcus aureus as a community-
acquired methicillin-resistant clone. Lancet 2005; 365: 1256–
1258.
26. Enright MC, Day NPJ, Davies CE et al. Multilocus
sequence typing for characterization of methicillin-resistant
and methicillin-susceptible clones of Staphylococcus aureus.
J Clin Microbiol 2000; 38: 1008–1015.
27. Kaneko J, Kimura T, Narita S et al. Complete nucleotide
sequence and molecular characterization of the temperate
staphylococcal bacteriophage phiPVL carrying Panton–
Valentine leukocidin genes. Gene 1998; 215: 57–67.
28. Kaneko J, Kimura T, Kawakami Y et al. Panton–Valentine
leukocidin genes in a phage-like particle isolated from
mitomycin C-treated Staphylococcus aureus V8
(ATCC 49775). Biosci Biotechnol Biochem 1997; 61: 1960–
1962.
29. Ito T, Okuma K, Ma XX et al. Insights on antibiotic resis-
tance of Staphylococcus aureus from its whole genome:
genomic island SCC. Drug Resist Updat 2003; 6: 41–52.
30. Ito T, Katayama Y, Asada K et al. Structural comparison of
three types of staphylococcal cassette chromosome mec
integrated in the chromosome in methicillin-resistant
Staphylococcus aureus. Antimicrob Agents Chemother 2001; 45:
1323–1336.
31. Oliveira DC, Wu SW, de Lencastre H. Genetic organization
of the downstream region of the mecA element in methi-
cillin-resistant Staphylococcus aureus isolates carrying dif-
ferent polymorphisms of this region. Antimicrob Agents
Chemother 2000; 44: 1906–1910.
32. Monecke S, Ehricht R. Rapid genotyping of methicillin-
resistant Staphylococcus aureus (MRSA) isolates using
miniaturised oligonucleotide arrays. Clin Microbiol Infect
2005; 11: 825–833.
33. Harmsen D, Claus H, Witte W et al. Typing of methicillin-
resistant Staphylococcus aureus in a university hospital set-
ting by using novel software for spa repeat determination
and database management. J Clin Microbiol 2003; 41: 5442–
5448.
34. Witte W, Cuny C, Strommenger B et al. Emergence of a
new community acquired MRSA strain in Germany. Euro
Surveill 2004; 9: 1–2.
35. Tenover FC, McDougal LK, Goering RV et al. Character-
ization of a strain of community-associated methicillin-
resistant Staphylococcus aureus widely disseminated in the
United States. J Clin Microbiol 2006; 44: 108–118.
36. Diep BA, Gill SR, Chang RF et al. Complete genome
sequence of USA300, an epidemic clone of community-
acquired methicillin-resistant Staphylococcus aureus. Lancet
2006; 367: 731–739.
37. Enright MC, Robinson DA, Randle G et al. The evolu-
tionary history of methicillin-resistant Staphylococcus
aureus (MRSA). Proc Natl Acad Sci USA 2002; 99: 7687–
7692.
38. Witte W, Cuny C, Braulke C et al. Widespread dissemi-
nation of epidemic MRSA in German hospitals. Euro
Surveill 1997; 2: 25–28.
39. Witte W, Enright M, Schmitz FJ et al. Characteristics of a
new epidemic MRSA in Germany ancestral to United
Kingdom EMRSA 15. Int J Med Microbiol 2001; 290: 677–
682.
40. Mu¨ller-Premru M, Strommenger B, Alikadic N et al. New
strains of community-acquired methicillin-resistant
Staphylococcus aureus with Panton–Valentine leukocidin
causing an outbreak of severe soft tissue infection in a
football team. Eur J Clin Microbiol Infect Dis 2005; 24: 848–
850.
41. Munckhof WJ, Schooneveldt J, Coombs GW et al. Emer-
gence of community-acquired methicillin-resistant Staph-
ylococcus aureus (MRSA) infection in Queensland,
Australia. Int J Infect Dis 2003; 7: 259–264.
42. Moran GJ, Krishnadasan A, Gorwitz RJ et al. Methicillin-
resistant S. aureus infections among patients in the emer-
gency department. N Engl J Med 2006; 355: 666–674.
43. Frazee BW, Lynn J, Charlebois ED et al.High prevalence of
methicillin-resistant Staphylococcus aureus in emergency
department skin and soft tissue infections. Ann Emerg Med
2005; 45: 311–320.
1164 Clinical Microbiology and Infection, Volume 13 Number 12, December 2007
 2007 The Authors
Journal Compilation  2007 European Society of Clinical Microbiology and Infectious Diseases, CMI, 13, 1157–1164
